Slocum Gordon & Co LLP Has $978,000 Holdings in Colgate-Palmolive Company $CL

Slocum Gordon & Co LLP lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 40.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,373 shares of the company’s stock after selling 8,523 shares during the quarter. Slocum Gordon & Co LLP’s holdings in Colgate-Palmolive were worth $978,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Maseco LLP acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Copia Wealth Management acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $29,000. Cloud Capital Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $30,000. Global Wealth Strategies & Associates increased its stake in Colgate-Palmolive by 300.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after buying an additional 300 shares during the period. Finally, Grove Bank & Trust increased its stake in Colgate-Palmolive by 182.6% in the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after buying an additional 263 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

CL stock opened at $85.83 on Friday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company has a market capitalization of $68.86 billion, a price-to-earnings ratio of 32.76, a P/E/G ratio of 4.16 and a beta of 0.34. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a 50 day moving average of $89.99 and a two-hundred day moving average of $83.71.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a $0.53 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s payout ratio is presently 79.39%.

Analyst Ratings Changes

Several research analysts have weighed in on CL shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Barclays dropped their price objective on shares of Colgate-Palmolive from $88.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Tuesday. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 price objective on shares of Colgate-Palmolive in a research note on Friday, February 20th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Jefferies Financial Group upped their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $95.44.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the sale, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.43% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.